STAT Plus: Gottlieb ‘extremely worried’ about how to pay for CAR-T therapies
MICHAEL REYNOLDS/EPA
His comments are the strongest indication that the FDA might have a role in the debate over paying for the CAR-T therapies.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario